Da Liu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Survival of lung cancer patients with central nervous system metastases: from clinical trials to mouse models.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 03, 2025
Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer.
Journal: Cell discovery
Published: March 27, 2025
Driver Genes and Genomic Instability Predict the Incidence and Outcome of Brain Metastases.
Journal: Current cancer drug targets
Published: February 13, 2025
Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 06, 2024
PMS2 amplification contributes brain metastasis from lung cancer.
Journal: Biological procedures online
Published: March 01, 2024
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases.
Journal: Heliyon
Published: March 19, 2023
Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome.
Journal: BMC cancer
Published: January 30, 2023
Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma.
Journal: Experimental hematology & oncology
Published: November 15, 2022
EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome.
Journal: Frontiers in oncology
Published: March 23, 2022
A non-small cell lung cancer (NSCLC) patient with leptomeningeal metastasis harboring rare epidermal growth factor receptor (EGFR) mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report.
Journal: Annals of palliative medicine
Published: September 24, 2020
Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study.
Journal: Radiation oncology (London, England)
Published: April 22, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026